NCT04123769View on ClinicalTrials.gov

Study on PK of Hydronidone in Patients and Special Population

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 3, 2019

Primary Completion Date

October 9, 2020

Study Completion Date

January 30, 2021

Conditions
Hepatitis b & Liver Dysfunction
Interventions
DRUG

Hydronidone

First take Hydronidone capsule, single-dose and then Multiple-dose

Trial Locations (1)

Unknown

Medical ethics committee of wuhan infectious disease hospital, Wuhan

All Listed Sponsors
lead

Beijing Continent Pharmaceutical Co, Ltd.

INDUSTRY

NCT04123769 - Study on PK of Hydronidone in Patients and Special Population | Biotech Hunter | Biotech Hunter